Aprea Therapeutics APRE
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 4.07 | 26 | -12.74 | -3 | -10.99 | 30 |
| 2024Q1 | 6.69 | 29 | -12.25 | -3 | -10.06 | 33 |
| 2023Q4 | 4.70 | 17 | -18.49 | -3 | -14.22 | 23 |
| 2023Q3 | 4.17 | 20 | -14.67 | -3 | -11.77 | 26 |
| 2023Q2 | 3.15 | 23 | -13.06 | -3 | -10.74 | 29 |
| 2023Q1 | 4.44 | 26 | -16.81 | -4 | -14.09 | 32 |
| 2022Q4 | 6.62 | 26 | -9.34 | -2 | -7.66 | 30 |
| 2022Q3 | 13.00 | 27 | -4 | -10.83 | 34 | |
| 2022Q2 | 15.00 | -36 | -98 | -215.90 | 41 | |
| 2022Q1 | 37.20 | 44 | -17.05 | -8 | -14.81 | 50 |
| 2021Q4 | 57.40 | 50 | -15.07 | -8 | -13.00 | 57 |
| 2021Q3 | 102.20 | 53 | -16.53 | -9 | -14.10 | 62 |
| 2021Q2 | 97.60 | 61 | -15.76 | -10 | -13.49 | 72 |
| 2021Q1 | 102.00 | 69 | -13.20 | -10 | -11.17 | 80 |
| 2020Q4 | 98.40 | 77 | -18.50 | -15 | -15.74 | 93 |
| 2020Q3 | 481.20 | 89 | -13.03 | -12 | -11.32 | 103 |
| 2020Q2 | 775.60 | 100 | -15.33 | -16 | -13.64 | 115 |
| 2020Q1 | 695.20 | 113 | -7.91 | -9 | -7.27 | 125 |
| 2019Q4 | 917.80 | 124 | -13 | -13.69 | 134 | |
| 2019Q3 | -71 | -6 | 57 |